Literature DB >> 31740580

Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion.

Deviyani M Rao1, Madeleine T Shackleford1, Evelyn K Bordeaux1, Joseph L Sottnik1, Rebecca L Ferguson1, Tomomi M Yamamoto2, Elizabeth A Wellberg1, Benjamin G Bitler2, Matthew J Sikora3.   

Abstract

Porcupine O-acyltransferase (PORCN) is considered essential for Wnt secretion and signaling. However, we observed that PORCN inhibition does not phenocopy the effects of WNT4 knockdown in WNT4-dependent breast cancer cells. This suggests a unique relationship between PORCN and WNT4 signaling. To examine the role of PORCN in WNT4 signaling, here we overexpressed WNT4 or WNT3A in breast cancer, ovarian cancer, and fibrosarcoma cell lines. Conditioned media from these lines and co-culture systems were used to assess the dependence of Wnt secretion and activity on the critical Wnt secretion proteins PORCN and Wnt ligand secretion (WLS) mediator. We observed that WLS is universally required for Wnt secretion and paracrine signaling. In contrast, the dependence of WNT3A secretion and activity on PORCN varied across the cell lines, and WNT4 secretion was PORCN-independent in all models. Surprisingly, WNT4 did not exhibit paracrine activity in any tested context. Absent the expected paracrine activity of secreted WNT4, we identified cell-autonomous Wnt signaling activation by WNT4 and WNT3A, independent of PORCN or Wnt secretion. The PORCN-independent, cell-autonomous Wnt signaling demonstrated here may be critical in WNT4-driven cellular contexts or in those that are considered to have dysfunctional Wnt signaling.
© 2019 Rao et al.

Entities:  

Keywords:  PORCN; WNT3A; WNT4; Wnt pathway; Wnt signaling; breast cancer; cancer biology; cell growth; cell signaling; glycoprotein secretion; ovarian cancer; protein secretion

Mesh:

Substances:

Year:  2019        PMID: 31740580      PMCID: PMC6937561          DOI: 10.1074/jbc.RA119.009615

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification.

Authors:  Gary S Coombs; Jia Yu; Claire A Canning; Charles A Veltri; Tracy M Covey; Jit K Cheong; Velani Utomo; Nikhil Banerjee; Zong Hong Zhang; Raquel C Jadulco; Gisela P Concepcion; Tim S Bugni; Mary Kay Harper; Ivana Mihalek; C Michael Jones; Chris M Ireland; David M Virshup
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

2.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.

Authors:  Manabu Kurayoshi; Hideki Yamamoto; Shunsuke Izumi; Akira Kikuchi
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

3.  Progesterone induces adult mammary stem cell expansion.

Authors:  Purna A Joshi; Hartland W Jackson; Alexander G Beristain; Marco A Di Grappa; Patricia A Mote; Christine L Clarke; John Stingl; Paul D Waterhouse; Rama Khokha
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

4.  Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk.

Authors:  Renuga Devi Rajaram; Duje Buric; Marian Caikovski; Ayyakkannu Ayyanan; Jacques Rougemont; Jingdong Shan; Seppo J Vainio; Ozden Yalcin-Ozuysal; Cathrin Brisken
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

5.  Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy.

Authors:  Brian K Jordan; Jennifer H-C Shen; Robert Olaso; Holly A Ingraham; Eric Vilain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

6.  BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.

Authors:  Georges Rawadi; Béatrice Vayssière; Fred Dunn; Roland Baron; Sergio Roman-Roman
Journal:  J Bone Miner Res       Date:  2003-10       Impact factor: 6.741

7.  R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling.

Authors:  Kazuma Tomizuka; Kaori Horikoshi; Rina Kitada; Yuriko Sugawara; Yumi Iba; Ayako Kojima; Akiko Yoshitome; Kengo Yamawaki; Mikiko Amagai; Ayano Inoue; Takeshi Oshima; Makoto Kakitani
Journal:  Hum Mol Genet       Date:  2008-02-04       Impact factor: 6.150

8.  Wnt4 participates in the formation of vertebrate neuromuscular junction.

Authors:  Laure Strochlic; Julien Falk; Evelyne Goillot; Séverine Sigoillot; Francine Bourgeois; Perrine Delers; Jérôme Rouvière; Amanda Swain; Valérie Castellani; Laurent Schaeffer; Claire Legay
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  Wnt4 coordinates directional cell migration and extension of the Müllerian duct essential for ontogenesis of the female reproductive tract.

Authors:  Renata Prunskaite-Hyyryläinen; Ilya Skovorodkin; Qi Xu; Ilkka Miinalainen; Jingdong Shan; Seppo J Vainio
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

10.  Wnt4 is not sufficient to induce lobuloalveolar mammary development.

Authors:  Young Chul Kim; Rod J Clark; Francisco Pelegri; Caroline M Alexander
Journal:  BMC Dev Biol       Date:  2009-10-30       Impact factor: 1.978

View more
  8 in total

1.  Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion.

Authors:  Deviyani M Rao; Madeleine T Shackleford; Evelyn K Bordeaux; Joseph L Sottnik; Rebecca L Ferguson; Tomomi M Yamamoto; Elizabeth A Wellberg; Benjamin G Bitler; Matthew J Sikora
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

Review 2.  WNT4 Balances Development vs Disease in Gynecologic Tissues and Women's Health.

Authors:  Lauren M Pitzer; Marisa R Moroney; Natalie J Nokoff; Matthew J Sikora
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

3.  Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast.

Authors:  Joseph L Sottnik; Evelyn K Bordeaux; Sanjana Mehrotra; Sarah E Ferrara; Andrew E Goodspeed; James C Costello; Matthew J Sikora
Journal:  Mol Cancer Res       Date:  2021-05-04       Impact factor: 5.852

Review 4.  Wnt Signaling in Gynecologic Malignancies.

Authors:  Alexandra McMellen; Elizabeth R Woodruff; Bradley R Corr; Benjamin G Bitler; Marisa R Moroney
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

5.  A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling.

Authors:  Zhi-Jie Xia; Xin-Xin I Zeng; Mitali Tambe; Bobby G Ng; P Duc S Dong; Hudson H Freeze
Journal:  Front Cell Dev Biol       Date:  2021-09-14

Review 6.  Roles and action mechanisms of WNT4 in cell differentiation and human diseases: a review.

Authors:  Quanlong Zhang; Yan Pan; Jingjing Ji; Yuxin Xu; Qiaoyan Zhang; Luping Qin
Journal:  Cell Death Discov       Date:  2021-10-12

Review 7.  Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence.

Authors:  Emma H van Schie; Renée van Amerongen
Journal:  Front Cell Dev Biol       Date:  2020-01-31

8.  Estrogen Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular Carcinoma Cell Lines Requires WNT4.

Authors:  Madeleine T Shackleford; Deviyani M Rao; Evelyn K Bordeaux; Hannah M Hicks; Christina G Towers; Joseph L Sottnik; Steffi Oesterreich; Matthew J Sikora
Journal:  Cancers (Basel)       Date:  2020-10-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.